Your session is about to expire
← Back to Search
Visual feedback of symptom frequency for Bulimia
N/A
Waitlist Available
Led By Michele M Laliberte, Ph.D.
Research Sponsored by St. Joseph's Healthcare Hamilton
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
BMI (Body Mass Index) over 19
Diagnosis of Bulimia Nervosa, Binge Eating Disorder, or Other Specified Feeding and Eating Disorder (OSFED) Purging Disorder.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at week 6, 10, and up to 25 weeks (end of group treatment)
Awards & highlights
Study Summary
This study is evaluating whether providing visual graphs of eating disorder symptoms in the early sessions of treatment will lead to higher rates of rapid response in patients with eating disorders.
Eligible Conditions
- Bulimia
- Binge Eating Disorder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at week 6, 10, and up to 25 weeks (end of group treatment)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at week 6, 10, and up to 25 weeks (end of group treatment)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in eating disorder symptoms from baseline
Secondary outcome measures
Eating Disorders
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Visual feedback of symptom frequencyExperimental Treatment1 Intervention
Participants in this arm receive visual feedback of their symptom frequency over the first 4 weeks of active treatment, based on information they provide on a symptom checklist.
Group II: No visual feedback of symptom frequencyActive Control1 Intervention
Participants in this arm complete the symptom checklist as is typically done during treatment, but receive no visual feedback of their self-reported symptom frequency over the first 4 weeks of active treatment.
Find a Location
Who is running the clinical trial?
St. Joseph's Healthcare HamiltonLead Sponsor
195 Previous Clinical Trials
25,344 Total Patients Enrolled
1 Trials studying Bulimia
160 Patients Enrolled for Bulimia
Michele M Laliberte, Ph.D.Principal InvestigatorSt. Joseph's Healthcare Hamilton
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger